These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 21068200)

  • 1. O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.
    Lima VV; Giachini FR; Hardy DM; Webb RC; Tostes RC
    Am J Physiol Regul Integr Comp Physiol; 2011 Feb; 300(2):R236-50. PubMed ID: 21068200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway.
    Lima VV; Giachini FR; Carneiro FS; Carvalho MH; Fortes ZB; Webb RC; Tostes RC
    Cardiovasc Res; 2011 Feb; 89(3):614-22. PubMed ID: 20978008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein O-GlcNAcylation: a new signaling paradigm for the cardiovascular system.
    Laczy B; Hill BG; Wang K; Paterson AJ; White CR; Xing D; Chen YF; Darley-Usmar V; Oparil S; Chatham JC
    Am J Physiol Heart Circ Physiol; 2009 Jan; 296(1):H13-28. PubMed ID: 19028792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcylation contributes to augmented vascular reactivity induced by endothelin 1.
    Lima VV; Giachini FR; Carneiro FS; Carneiro ZN; Saleh MA; Pollock DM; Fortes ZB; Carvalho MH; Ergul A; Webb RC; Tostes RC
    Hypertension; 2010 Jan; 55(1):180-8. PubMed ID: 19948983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter?
    Lima VV; Spitler K; Choi H; Webb RC; Tostes RC
    Clin Sci (Lond); 2012 Oct; 123(8):473-86. PubMed ID: 22757958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hexosamine signaling pathway: deciphering the "O-GlcNAc code".
    Love DC; Hanover JA
    Sci STKE; 2005 Nov; 2005(312):re13. PubMed ID: 16317114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. O-GlcNAc modification, insulin signaling and diabetic complications.
    Issad T; Masson E; Pagesy P
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):423-35. PubMed ID: 21074472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated.
    Zhang S; Roche K; Nasheuer HP; Lowndes NF
    J Biol Chem; 2011 Oct; 286(43):37483-95. PubMed ID: 21896475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O-GlcNAcylation and cardiovascular disease.
    Wright JN; Collins HE; Wende AR; Chatham JC
    Biochem Soc Trans; 2017 Apr; 45(2):545-553. PubMed ID: 28408494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Increases in Protein O-GlcNAcylation Dampen Epileptiform Activity in Hippocampus.
    Stewart LT; Khan AU; Wang K; Pizarro D; Pati S; Buckingham SC; Olsen ML; Chatham JC; McMahon LL
    J Neurosci; 2017 Aug; 37(34):8207-8215. PubMed ID: 28760863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. O-GlcNAc modification affects the ATM-mediated DNA damage response.
    Miura Y; Sakurai Y; Endo T
    Biochim Biophys Acta; 2012 Oct; 1820(10):1678-85. PubMed ID: 22759405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation: a novel post-translational mechanism to alter vascular cellular signaling in health and disease: focus on hypertension.
    Lima VV; Rigsby CS; Hardy DM; Webb RC; Tostes RC
    J Am Soc Hypertens; 2009; 3(6):374-87. PubMed ID: 20409980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O-GlcNAc signaling in the cardiovascular system.
    Ngoh GA; Facundo HT; Zafir A; Jones SP
    Circ Res; 2010 Jul; 107(2):171-85. PubMed ID: 20651294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
    Belke DD
    J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. O-Glycosylation with O-linked β-N-acetylglucosamine increases vascular contraction: Possible modulatory role on Interleukin-10 signaling pathway.
    Miguez JSG; Dela Justina V; Bressan AFM; Marchi PGF; Honorio-França AC; Carneiro FS; Clinton Webb R; Tostes RC; Giachini FR; Lima VV
    Life Sci; 2018 Sep; 209():78-84. PubMed ID: 30075176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.
    Hart GW; Slawson C; Ramirez-Correa G; Lagerlof O
    Annu Rev Biochem; 2011; 80():825-58. PubMed ID: 21391816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-linked β-N-acetylglucosamine supports p38 MAPK activation by high glucose in glomerular mesangial cells.
    Goldberg H; Whiteside C; Fantus IG
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E713-26. PubMed ID: 21712532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. O-GlcNAcylation in health and neurodegenerative diseases.
    Lee BE; Suh PG; Kim JI
    Exp Mol Med; 2021 Nov; 53(11):1674-1682. PubMed ID: 34837015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic interplay between O-linked N-acetylglucosaminylation and glycogen synthase kinase-3-dependent phosphorylation.
    Wang Z; Pandey A; Hart GW
    Mol Cell Proteomics; 2007 Aug; 6(8):1365-79. PubMed ID: 17507370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.